ANALGESICS IN SWITZERLAND

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Demand for Analgesics Drops As Consumers Become Cautious

OTC Product Maturity Reduces Consumer Demand, But Regulation Discourages Investment in Innovation

Swiss Consumers Favour Insurance-covered Prescription Drugs

Competitive Landscape

in Spite of Falling Demand, Consumer Trust Drives Growth for Leading Brands

Small Companies More Active With Innovations

But Their Future Presence in Analgesics Is Threatened by Increasing Competition

Category Data

Table 1 Sales of Analgesics by Category: Value 2013-2018

Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 4 NBO Company Shares of Analgesics: % Value 2014-2018

Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Executive Summary

Demand Drops for Consumer Health, Leading To A Weaker Performance

High Costs Force Consumers To Find Ways To Save

Leading Brands Maintain Their Top Positions

Online Retailing Is Hit by Stringent Legislation

Consumer Health Set To See Slightly Positive Improvement Over the Forecast Period

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

Analgesics registered a value decline in 2018 as Swiss consumers continued to reduce their usage – a trend that has been evident for some time. Consumers are cautious about the potential adverse side effects of analgesics if used regularly over a long period of time, as warned by the medical establishment and the media. Many have stopped using these products for minor pains as they perceive that over usage leads to analgesics losing their effectiveness.

Euromonitor International's Analgesics in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.